Merck CEO Kenneth Frazier is sticking around. The New Jersey-based pharmaceutical giant said Wednesday that its board of directors had overturned a policy requiring CEOs to retire when they turn ...
During an hour-long, wide-ranging interview with the Economic Club of New York, Frazier, the CEO of New Jersey-based pharma giant Merck, addressed the issue of rising prescription drug costs and ...
As protests continue to engulf college campuses across the U.S., former Merck CEO Ken Frazier and former American Express CEO Ken Chenault see the unrest as a microcosm of broader society ...
Frazier stepped down as Merck CEO in February 2021 after nearly 30 years at the pharma group, including 10 years in the top job during which time he is credited with overseeing the fast ...
Merck Foundation, conducted the 11th Edition of their annual conference, "Merck Foundation Africa Asia Luminary".
The healthcare industry came together Wednesday to share thoughts on and reactions to the death of UnitedHealthcare CEO Brian ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ranked No. 1 on Newsweek’s annual list of America’s Most Responsible Companies for the second year in a row.
Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $103.55 which represents a slight increase of $2.18 or 2.15% from the prior close of $101.37. The stock opened at $101.49 and touched ...
Merck & Co’s CEO Kenneth Frazier has said the pharma industry must take on the challenge of its poor public perception. In an interview with Yahoo Finance, Frazier defended the industry’s ...
Eight months after snaring an inaugural FDA green light, Merck & Co. is bolstering the case for the chief asset in its $11.5 ...
Cambridge-based Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification ...